Skip to main content
  • English
    • Nederlands
    • Français

Home
  • Sign In
  • Therapeutic areas
    • Cardiology
      • Heart Failure
      • ASCVD
    • Dermatology
    • Hematology
      • ITP
    • Neurology
      • Multiple Sclerosis
    • Oncology
      • Breast Cancer
      • Prostate Cancer (mCRPC)
    • Ophthalmology
      • Retinal diseases
    • Respiratory
    • Rheumatology
  • Congresses & Events
    • Cardiology
      • BSC
      • ESC
    • Dermatology
      • EADV
      • Sharing is Caring
    • Hematology
      • ASH
      • EHA
      • ESH
    • Neurology
      • CMSC
      • EAN
      • ECTRIMS
    • Oncology
      • ASCO
      • ESMO
      • EBCC
      • SABCS
    • Rheumatology
      • Sharing is Caring
  • Contact

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

IMPACT event: Innovation and Multidisciplinary care with Pluvicto for Advanced mCRPC patients
Page protected by password
Netelroos - Doe the test
Search
  • Cosentyx® Letter for the consulting physician in case of treatment switch (Dutch)

      Download Dutch document     To receive by post, click on the "Add to card" button below
  • Cosentyx® Letter for the General Practitioner (Dutch)

      Download Dutch document     To receive by post, click on the "Add to card" button below
  • Cosentyx® - PSA

    Twitter Linkedin Facebook Pinterest Google plus
  • Efficacy - Cosentyx PsA

    Twitter Linkedin Facebook Pinterest Google plus
  • Reimbursement - Cosentyx PsA

    Twitter Linkedin Facebook Pinterest Google plus
  • Mechanism of action - Cosentyx PsA

    Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). 1 Cosentyx works by targeting IL-17A and inhibiting its interaction with...

    Twitter Linkedin Facebook Pinterest Google plus
  • Patient Resources - Cosentyx PsA

    Twitter Linkedin Facebook Pinterest Google plus
  • Dosing - Consentyx PsA

    Twitter Linkedin Facebook Pinterest Google plus
  • Useful tools & Links - Hematology

    Patient websites and organizations

    Belgian Hematology Society (BHS)

    The Belgian Hematology Society (BHS) is a...

    Twitter Linkedin Facebook Pinterest Google plus
  • Diagnostics

    The importance of early testing and early treatment

    To choose a suitable treatment for melanoma it is important to make the right diagnosis as soon as possible and to start treatment. On this page you can read more about the diagnosis for...

    Twitter Linkedin Facebook Pinterest Google plus
  • previous
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
 of  17
  • next

Filter by specialism:

Subscribe to Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sitemap
Cookie Settings
©2025 Novartis Belgium and Luxembourg
  • Terms of use
  • Privacy Policy
  • About cookies
This website is intended for health care professionals in Belgium and Luxembourg